PV Bulletin
Veterinary Medicines Directorate (VMD)United Kingdom

New digital service for MAHs to report safety data

The Veterinary Medicines Directorate (VMD) launched a new digital service for Marketing Authorisation Holders (MAHs) to submit pharmacovigilance reports, streamlining the submission process.

PV Impact Brief

Urgency: HighConfidence: high
Relevant for
Regulatory Intelligence LeadSignal Management LeadQPPV
Processes impacted
ICSRSignal ManagementCountry Compliance
Action needed

MAHs are encouraged to transition to the new digital service for all pharmacovigilance reporting and utilize the feedback function during the beta phase to improve the service.

Owner

Regulatory Intelligence Lead

Review cadence

Review before 2026-07-10.

Policy change details

Document type
Notice
Policy status
effective
Publication date
2026-07-10
Effective date
2026-07-10
Policy change
The Veterinary Medicines Directorate (VMD) has launched a new digital service for Marketing Authorisation Holders (MAHs) to submit pharmacovigilance reports. This service centralizes various submission types, including Benefit-Risk Submission Reports, signal notifications, and XML reports, into a single platform.

Key changes

Launch of the VMD Industry Pharmacovigilance Reporting Service. It supports submission of Benefit-Risk reports, signal notifications, Pharmacovigilance Sales Submissions, and XML reports. Features include submission status tracking and exportable logs. It is currently in beta but available for use.

Affected workflows

ICSRSignal ManagementCountry Compliance

Responsible groups

Pharmacovigilance OperationsIT/SystemsQPPV

PV impact

MAHs for veterinary medicines should transition to the new digital service for submitting safety data and signal notifications. While optional during the beta phase, it is designed to replace the VMDS secure messaging service over time.

View regulator source

Source document details

Exact policy details

Launch Date of New Digital Service for MAHs
10 July 2026
Applies to: Marketing Authorisation Holders (MAHs) of animal medicines
A new digital service for Marketing Authorisation Holders (MAHs) of animal medicines to submit pharmacovigilance reports to the Veterinary Medicines Directorate (VMD) went live on 10 July 2026. · p. 1 · High · Source
Launch Date of Adverse Event Reporting Service
20 May 2026
Applies to: Animal owners, veterinary professionals, and Suitably Qualified Persons
This follows the launch of our Adverse Event Reporting Service for use by animal owners, veterinary professionals and Suitably Qualified Persons on 20 May 2026. · p. 1 · High · Source

Workflow rule impacts

Country Compliance | ICSR | Signal ManagementMarketing Authorisation Holders (MAHs)

More efficient and user-friendly experience for MAHs

Integration of multiple submission types into a single platform

The service has been designed to make it easier for MAHs to fulfil their legislative requirements, offering a more efficient and user-friendly experience than previous reporting routes. · p. 1 · High · Source
Country ComplianceMarketing Authorisation Holders (MAHs)

MAHs can choose whether to adopt new reporting system or continue with existing methods

Optional use of new digital service during beta version

The service is being released as an optional beta version, and MAHs are encouraged to use the feedback function within the service to share their experience. · p. 1 · High · Source

Evidence and confidence

Confidence: highSource updated: Jul 10, 2026

Full briefing

What changed

The launch of the new VMD Industry Pharmacovigilance Reporting Service effective from July 10, 2026, allows MAHs to submit safety data through a centralized digital platform, integrating multiple submission types.

Why it matters

This new service enhances the efficiency and user-friendliness of reporting obligations, helping MAHs comply with legislative requirements.

Practical implication

MAHs are encouraged to transition to the new digital service for all pharmacovigilance reporting and utilize the feedback function during the beta phase to improve the service.

Related updates for your role

publicTherapeutic Goods Administration (TGA) · Australia · Updated Jul 7, 2026

Industry Standards for Medicinal Cannabis Vaping Devices - TGA Guidance

Urgency: High

Manufacturers must generate and maintain scientific, engineering, and clinical evidence demonstrating that their devices meet the Essential Principles for Safety and Performance.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Guidance
Read impact briefarrow_forward
publicHealth Sciences Authority (HSA) Singapore · Singapore · Updated Jun 30, 2026

Extension of e-labelling to P and GSL medicines

Urgency: High

Manufacturers must adjust labeling workflows to incorporate e-labelling mechanisms, such as QR codes, for P and GSL medicines by the stipulated date.

LabelingRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead, QPPV
verifiedRegulatory action: Regulatory Update / Notice
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Jul 10, 2026

PRAC 6-9 July 2026: Agrees new safety information on desogestrel- and etonogestrel-containing contraceptives and Litfulo, a medicine to treat alopecia areata News Human Pharmacovigilance Download medicine d

Urgency: High

MAHs must execute safety communication plans, update Risk Management Plans (RMPs), and revise product information including the Summary of Product Characteristics (SmPC) and Package Leaflet.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact3 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, Labeling Lead
verifiedRegulatory action: Meeting Highlights
Read impact briefarrow_forward
publicTherapeutic Goods Administration (TGA) · Australia · Updated Jul 8, 2026

New e-Learning Modules for GCP Inspection Program by TGA

Urgency: High

Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.

Inspection ReadinessCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead, QPPV
verifiedRegulatory action: Notice
Read impact briefarrow_forward